A Dynamic Metabolic Flux Analysis of Myeloid-Derived Suppressor Cells Confirms Immunosuppression-Related Metabolic Plasticity

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Goffaux, Guillaume ^a   Hammami, Iness ^a   Jolicoeur, Mario ^a  

^a ÉCOLE POLYTECHNIQUE DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ENERGY METABOLISM; IMMUNOLOGY; IMMUNOMODULATION; METABOLIC FLUX ANALYSIS; METABOLISM; METABOLOME; METABOLOMICS; MOUSE; MYELOID-DERIVED SUPPRESSOR CELL; PROCEDURES;

ANIMALS; ENERGY METABOLISM; IMMUNOMODULATION; METABOLIC FLUX ANALYSIS; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; METABOLOMICS; MICE; MYELOID-DERIVED SUPPRESSOR CELLS;

EID: 85028455766     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-10464-1     Document Type: Article

References (29)

1. Mahoney, K. M., Rennert, P. D. & Freeman, G. J. Combination cancer immunotherapy and new immunomodulatory targets. Nature reviews. Drug discovery 14, 561-584, doi:10.1038/nrd4591 (2015).
2. Gabrilovich, D. I. et al. The terminology issue for myeloid-derived suppressor cells. Cancer research 67, 425, author reply 426, doi: 10.1158/0008-5472.can-06-3037 (2007).
3. Serafini, P., Borrello, I. & Bronte, V. Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Seminars in cancer biology 16, 53-65, doi:10.1016/j.semcancer.2005.07.005 (2006).
4. Mocellin, S., Bronte, V. & Nitti, D. Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities. Medicinal research reviews 27, 317-352, doi:10.1002/med.20092 (2007).
5. Krawczyk, C. M. et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 115, 4742-4749, doi:10.1182/blood-2009-10-249540 (2010).
6. Van den Bossche, J., Baardman, J. & de Winther, M. P. Metabolic Characterization of Polarized M1 and M2 Bone Marrow-derived Macrophages Using Real-time Extracellular Flux Analysis. Journal of visualized experiments: JoVE. doi:10.3791/53424 (2015).
7. Hammami, I., Chen, J., Bronte, V., De Crescenzo, G. & Jolicoeur, M. L-glutamine is a key parameter in the immunosuppression phenomenon. Biochemical and biophysical research communications 425, 724-729, doi:10.1016/j.bbrc.2012.07.139 (2012).
8. Hammami, I. et al. Immunosuppressive activity enhances central carbon metabolism and bioenergetics in myeloid-derived suppressor cells in vitro models. BMC cell biology 13, 18, doi:10.1186/1471-2121-13-18 (2012).
9. Robitaille, J., Chen, J. & Jolicoeur, M. A Single Dynamic Metabolic Model Can Describe mAb Producing CHO Cell Batch and Fed-Batch Cultures on Different Culture Media. PloS one 10, e0136815, doi:10.1371/journal.pone.0136815 (2015).
10. Ghorbaniaghdam, A., Henry, O. & Jolicoeur, M. A kinetic-metabolic model based on cell energetic state: study of CHO cell behavior under Na-butyrate stimulation. Bioprocess and biosystems engineering 36, 469-487, doi:10.1007/s00449-012-0804-3 (2013).
11. Ghorbaniaghdam, A., Chen, J., Henry, O. & Jolicoeur, M. Analyzing clonal variation of monoclonal antibody-producing CHO cell lines using an in silico metabolomic platform. PloS one 9, e90832, doi:10.1371/journal.pone.0090832 (2014).
12. Hensley, C. T. et al. Metabolic Heterogeneity in Human Lung Tumors. Cell 164(4), 681-694 (2016).
13. Gentric, G., Mieulet, V. & Mechta-Grigoriou, F. Heterogeneity in Cancer Metabolism: New Concepts in an Old Field. Antioxid Redox Signal. Epub ahead of print (2016).
14. Marigo, I. et al. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 32, 790-802, doi:10.1016/j.immuni.2010.05.010 (2010).
15. Kimball, E. & Rabinowitz, J. D. Identifying decomposition products in extracts of cellular metabolites. Analytical biochemistry 358, 273-280, doi:10.1016/j.ab.2006.07.038 (2006).
16. Cloutier, M., Perrier, M. & Jolicoeur, M. Dynamic flux cartography of hairy roots primary metabolism. Phytochemistry 68, 2393-2404 (2007).
17. Cloutier, M. et al. Kinetic metabolic modelling for the control of plant cells cytoplasmic phosphate. Journal of theoretical biology 259, 118-131, doi:10.1016/j.jtbi.2009.02.022 (2009).
18. Ghorbaniaghdam, A., Henry, O. & Jolicoeur, M. An in-silico study of the regulation of CHO cells glycolysis. Journal of theoretical biology 357, 112-122, doi:10.1016/j.jtbi.2014.04.035 (2014).
19. Hundal, H. S., Rennie, M. J. & Watt, P. W. Characteristics of acidic, basic and neutral amino acid transport in the perfused rat hindlimb. The Journal of Physiology 408, 93-114 (1989).
20. Ahn, W. S. & Antoniewicz, M. R. Metabolic flux analysis of CHO cells at growth and non-growth phases using isotopic tracers and mass spectrometry. Metabolic engineering 13, 598-609, doi:10.1016/j.ymben.2011.07.002 (2011).
21. Viale, A., Corti, D. & Draetta, G. F. Tumors and Mitochondrial Respiration: A Neglected Connection. Cancer research. doi:10.1158/0008-5472.can-15-0491 (2015).
22. Desideri, E., Vegliante, R. & Ciriolo, M. R. Mitochondrial dysfunctions in cancer: genetic defects and oncogenic signaling impinging on TCA cycle activity. Cancer letters 356, 217-223, doi:10.1016/j.canlet.2014.02.023 (2015).
23. Lehninger, A. Biochemistry. (Worth, 1977).
24. Koivunen, P. et al. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. The Journal of biological chemistry 282, 4524-4532, doi:10.1074/jbc.M610415200 (2007).
25. Corzo, C. A. et al. HIF-1alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. The Journal of experimental medicine 207, 2439-2453, doi:10.1084/jem.20100587 (2010).
26. Benito, A., Diaz-Moralli, S., Coy, J., Centelles, J. & Cascante, M. In Tumor Cell Metabolism: Pathways, Regulation and Biology (eds Sybille Mazurek & Maria Shoshan) 143-163 (2015).
27. Murphy, C. & Newsholme, P. Importance of glutamine metabolism in murine macrophages and human monocytes to L-arginine biosynthesis and rates of nitrite or urea production. Clinical science (London, England: 1979) 95, 397-407 (1998).
28. Draghiciu, O., Lubbers, J., Nijman, H. W. & Daemen, T. Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy. Oncoimmunology 4, e954829, doi:10.4161/21624011.2014.954829 (2015).
29. Germain, R. N., Meier-Schellersheim, M., Nita-Lazar, A. & Fraser, I. D. C. Systems Biology in Immunology - A Computational Modeling Perspective. Annu Rev Immunol. 29, 527-585 (2011).